Tarsus Pharmaceuticals
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Tarsus Pharmaceuticals's balance sheet done over the years? Its assets were worth $265,491,000 last year, which is more than in the previous period. 26% of Tarsus Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $68,503,000, which means an increase by 96% compared compared to last year.

Debt to Assets

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS): Debt to assets
2018 2389000 3.74M 156.68%
2019 58316000 64.32M 110.3%
2020 171972000 5.99M 3.48%
2021 178907000 12.17M 6.81%
2022 227863000 34.96M 15.34%
2023 265491000 68.50M 25.8%

TARS Balance Sheet (2018 – 2023)

2023 2022 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
224.94M71.66M171.33M168.12M57.95M2.35M
Short term investments
2.49M145.36M483K000
Net receivables
17.71M3.58M92K20K36K4K
Inventory
3.10M4.76M0020K0
Other current assets
7.86M4.76K4.04M2.50M22K24K
Total current assets
256.13M225.37M175.95M170.65M58.03M2.38M
Non-current assets:
Property, Plant and Equipment
3.34M1.53M1.82M1.23M280K6K
Goodwill
000000
Intangible assets
3.86M00000
Long term investments
631K371K663K000
Other non-current assets
1.51M585K463K81K6K0
Total non-current assets
9.36M2.48M2.95M1.31M286K6K
Total assets
265.49M227.86M178.90M171.97M58.31M2.38M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
00697K000
Short term debt
398K721K1.30M282K64K0
Total current liabilities
36.93M15.42M11.47M5.38M819K179K
Non-current liabilities:
Long term debt
31.33M19.43M585K549K100K0
Deferred tax
000000
Other non-current liabilities
233K100K114K56K63.40M3.56M
Total non-current liabilities
31.56M19.53M699K605K63.50M3.56M
Total liabilities
68.50M34.96M12.17M5.99M64.32M3.74M
Data sourceData sourceData sourceData source